Journal of diabetes science and technology
Supporting Good Intentions With Good Evidence: How to Increase the Benefits of Diabetes Social Media.
Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices.
Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.
A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
The Need for Accuracy in Hemoglobin A1c Proficiency Testing: Why the Proposed CLIA Rule of 2019 Is a Step Backward.
Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus.
The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics.
Elderly Patients With Diabetes: Special Aspects to Consider.
The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
New Opportunities for Digital Health to Thrive.
